Manufacturing

Chris Spivey is the editorial director of 

Articles

Revolutionary therapies restructure pharmaceutical manufacturing.

Leap Year

There are positive indications for future growth.

New Therapies Cry Out for New Skills

Tome Bioscience is facilitating the transition in biology from the editing phase to the cut-and-paste phase.

Tome brings $213 Million to the Programmable Genome Editing Party

Feliza Mirasol is the science editor for 

Andelyn Biosciences has been selected by Ultragenyx to manufacture UX111, that company’s gene therapy for treating Sanfilippo Syndrome.

Ultragenyx Picks Andelyn Biosciences to Manufacture Novel Gene Therapy for Sanfilippo Syndrome

RoslinCT will manufacture Vertex Pharmaceuticals’ CRISPR-based gene therapy, Casgevy, recently approved for treating sickle cell disease and β thalassemia.

RoslinCT to Manufacture CRISPR-Based Gene Therapy Casgevy

John Lewis, PhD, is CEO of Entos Pharmaceuticals.

Collaboration is a key component to achieving long-term success with genetic medicines.

Risks and Rewards of Investing in RNA-based Genetic Medicine Manufacturing

Exagamglogene autotemcel seen as synechdoche.

New Medicines, Markets, and Manufacture: CRISPR for Sickle Cell Disease and β-thalassemia

Jennifer Markarian is manufacturing editor of BioPharm International.

Emergence of advanced manufacturing technology to ensure quality of biopharmaceutical drugs combined with efforts to identify a regulatory pathway indicate that a distributed manufacturing model is within reach. 

Considering the Promises of Point-of-Care Manufacturing

Monoclonal antibody and viral vector manufacture share similarities, but vector scale up faces unique challenges.

Gleaning Scale-Up Lessons from mAbs for Viral Vectors

Spark Therapeutics and SpliceBio have formed a collaboration to develop a gene therapy that can treat an inherited retinal disease.

Manufacturing, Gene Therapies